Linezolid Kabi

Linezolid, the active ingredient in Linezolid Kabi, is an oxazolidinone antibiotic presented as an intravenous solution for IV use. It treats infections caused by susceptible Gram‑positive bacteria, including skin and soft‑tissue infections, community‑acquired and nosocomial pneumonia, and complicated bone or joint infections.

GNH USA supplies Linezolid Kabi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Linezolid Kabi is employed to manage bacterial infections where Gram‑positive pathogens are implicated.

- Skin and soft‑tissue infections: eradicates susceptible Gram‑positive organisms and promotes healing. - Community‑acquired and nosocomial pneumonia: provides bacteriostatic activity against the causative bacteria. - Bone and joint infections: penetrates deep tissues to clear complicated Gram‑positive infections.

Linezolid Kabi may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Diarrhea: loose stools, often self‑limiting. - Headache: transient cranial discomfort. - Vomiting: occasional emesis. - Metallic taste: altered taste perception. - Rash: mild skin erythema.

Serious or Rare Side Effects: - Thrombocytopenia: significant drop in platelet count. - Anemia: reduced hemoglobin levels. - Peripheral neuropathy: tingling or numbness in extremities. - Serotonin syndrome: potentially life‑threatening when combined with serotonergic agents. - Severe liver enzyme elevation: marked increase in hepatic transaminases. - Hypersensitivity reactions: including anaphylaxis and severe skin eruptions.

When prescribing Linezolid Kabi, clinicians should observe several safety measures.

- Monitor blood counts: watch for thrombocytopenia and anemia. - Assess renal function: adjust therapy if renal impairment is present. - Evaluate hepatic status: consider liver function tests before and during treatment. - Caution with serotonergic drugs: avoid concomitant use with MAO inhibitors or SSRIs. - Avoid in known hypersensitivity: discontinue if allergic reaction occurs. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Linezolid Kabi interacts with several drug classes; awareness of these interactions helps prevent adverse outcomes.

Major Interactions (Avoid): - MAO inhibitors: risk of severe hypertension and serotonin syndrome. - SSRIs/SNRIs: potential for serotonin syndrome. - Rifampin: reduces linezolid plasma concentrations. - Carbamazepine: decreases linezolid exposure. - Warfarin: may increase INR and bleeding risk.

Moderate Interactions (Monitor Closely): - NSAIDs: heightened bleeding tendency. - Ethanol: possible disulfiram‑like reaction. - Immunosuppressants (e.g., cyclosporine): monitor for altered drug levels.